A study published in the British Medical Journal on October 25, 2011 confirms that Yaz, Yasmin and Ocella are at least twice more likely to cause dangerous blood clots than other types of birth control pills.

Yaz, Yasmin, and Ocella also pose an increased risk of gallbladder disease as
compared to other common birth control pills.

DePuy has released the following statement to the public:
"Data recently received by the company shows that more people than expected who received the ASR Hip System experienced pain and other symptoms that led to a second hip replacement surgery, called a revision surgery. For this reason, DePuy Orthopaedics is voluntarily recalling its ASR(tm) XL Acetabular System and DePuy ASR(tm) Hip Resurfacing System. This recall means additional testing and treatment may be necessary to ensure the hip is functioning well. In some cases, patients may need additional surgery."

Yaz®/Yasmin®/Ocella®
The newest birth control litigation involves Bayer Healthcare Pharmaceuticals who is the manufacturer of Yaz® and Yasmin® birth control pills and Barr Laboratories and Teva Pharmaceuticals who are now the manufacturers of Ocella®, the generic form of Yasmin. In November 2009, the Judicial Panel on Multidistrict Litigation (JPMDL) granted a petition filed by plaintiffs and created a Yaz®/Yasmin® multidistrict litigation (MDL). All pending cases and all future lawsuits filed in the federal court system will be centralized for discovery purposes in the Southern District of Illinois before Judge David R. Herndon.

Public Citizen, a nonprofit consumer advocacy program, petitioned the FDA asking that it pull Ortho Evra from the market.

On December 22, 2005 the FDA issued a recall of Composix Kugel Mesh Patches used to repair ventral (incisional) hernias. Kugel Mesh Patches are manufactured by Davol, Inc., a subsidiary of C.R. Bard, Inc. The Kugel Mesh Patches were recalled because the "memory recoil ring" that opens the Patch can break after it has been inserted in the intra-abdominal (inside the belly area) space. This can lead to serious injuries, including bowel perforations and/or chronic intestinal problems, including abnormal connections between the intestines and other organs. Since the date of the initial recall, it has been determined that additional manufactured lots of the Patches were also defective and therefore, the recall notice has been expanded on multiple occasions, with the most recent recall date of January 10, 2007. Davol, Inc. has notified surgeons and hospitals to stop using the recalled products and return unused units to the company. The FDA has issued warnings to patients who have been implanted with these recalled devices to seek immediate medical attention if they experience symptoms that could be associated with ring breakage such as unexplained or persistent abdominal pain, fever, tenderness at the implant site or other unusual symptoms.

ST. LOUIS - Schlichter Bogard & Denton announces that it is investigating potential claims for injuries related to the use of a particular type of blood pressure medicine, called ACE inhibitors, during the first trimester of pregnancy. ACE inhibitors available in the United States include: captopril (Capoten), benazepril (Lotensin), enalapril (Vasotec), lisinopril (Prinivil, Zestril) fosinopril (Monopril), ramipril (Altace), perindopril (Aceon), quinapril (Accupril), moexipril (Univasc), and trandolapril (Mavik).

St. Louis could become a major player in nationwide legal action involving Raritan, N.J.-based drug maker Ortho-McNeil, following claims that the company's Ortho Evra birth-control patch may have caused blood clot problems and other serious side effects in users.

The popular contracreptive Ortho Evra is the target of seven product liability suits filed by women claiming the drug maker failed to warn them about the risk of developing blood clots.

ST. LOUIS - On December 16, 2005 Ms. Bintha Lewis, the guardian and representative of the estate of minor Ashley Lewis, deceased, filed a lawsuit in the St. Louis City Circuit Court against Ortho-McNeil Pharmaceuticals, Johnson & Johnson, Inc. along with Miss Lewis' St. Louis City medical doctors and two St. Louis City medical facilities in regard to the death of Miss Lewis as a result of using the Ortho Evra Birth Control Patch. The suit was brought by the firm of Schlichter Bogard & Denton in St. Louis. At the time of her death, Miss Lewis was seventeen years old and had a one year old child.